The intersection of neuroscience and medical technology has given rise to one of the most transformative therapeutic innovations of recent decades. The vagus nerve stimulator a small implantable or wearable device that delivers electrical impulses to the body’s longest cranial nerve is redefining how physicians approach conditions that have long resisted conventional pharmacological treatment. From…

Degenerative Disc Disease Treatment Advancements and the Shift Toward Regenerative Therapies Degenerative Disc Disease (DDD) is a major contributor to persistent spinal pain, reduced mobility, and disability, particularly among aging populations. As the burden of chronic lower back pain continues to increase, healthcare professionals and researchers are looking beyond conventional symptom-management strategies toward therapies that…

The Rising Role of AI in Mental Health The integration of AI in mental health is transforming the way psychological conditions are identified, monitored, and managed. From predictive analytics to conversational AI, AI for mental health is enabling faster interventions and expanding access to care. As the AI in mental health market continues to grow,…

Medical Marijuana: A Blessing in Disguise or a Curse for Humanity? The influx of companies, the launch of pipeline therapies, and the ongoing legalization of marijuana and cannabis are the major drivers reshaping the medical marijuana market today. Cannabis, popularly known as marijuana, is the most commonly used illicit drug after alcohol, with more than…

Dupixent (dupilumab) is a non-immunosuppressive, fully human monoclonal antibody that inhibits the signalling of interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins. According to data from Dupixent clinical trials, IL-4 and IL-13 are key drivers of type 2 inflammation — a major contributor to Atopic Dermatitis, Asthma, and Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP). How Is Dupixent…

Bipolar depression long known as manic depression remains one of the most complex and under-addressed areas of psychiatric medicine. As diagnosis rates improve and stigma around mental health continues to fall, the bipolar depression treatment market has become a genuine growth frontier for the pharmaceutical industry. According to DelveInsight’s “Bipolar Depression Market Insight, Epidemiology and…